This page shows the publications co-authored by Robert Mealer and Richard Cummings.
The schizophrenia risk locus in SLC39A8 alters brain metal transport and plasma glycosylation. Sci Rep. 2020 08 04; 10(1):13162.
Aberrant glycosylation in schizophrenia: a review of 25 years of post-mortem brain studies. Mol Psychiatry. 2020 12; 25(12):3198-3207.
Glycobiology and schizophrenia: a biological hypothesis emerging from genomic research. Mol Psychiatry. 2020 12; 25(12):3129-3139.
L-Fucose treatment of FUT8-CDG. Mol Genet Metab Rep. 2020 Dec; 25:100680.
N-glycome analysis detects dysglycosylation missed by conventional methods in SLC39A8 deficiency. J Inherit Metab Dis. 2020 11; 43(6):1370-1381.
The connection strength for co-authors is the sum of the scores for each of their shared publications.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.